TrialEuropean journal of pediatrics2026

Nine-year ocular developmental outcomes after ranibizumab or laser treatment for zone II retinopathy of prematurity: follow-up of a randomized trial cohort.

Yaling Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.